Literature DB >> 22821651

Inferior vena cava thrombectomy in a patient with heparin-induced thrombocytopenia via inflow occlusion technique on beating heart.

Faruk Cingoz1, Murat Tavlasoglu, Mehmet Ali Sahin, Mustafa Kurkluoglu.   

Abstract

Anticoagulation management of a patient complicated by heparin-induced thrombocytopenia is one of the challenging situations in open heart surgery. A 40-year old male receiving warfarin for anticoagulation was admitted to our clinic with a history of heparin-induced thrombocytopenia and a diagnosis of inferior caval thrombosis. He was scheduled for inferior vena cava thrombectomy via the inflow occlusion technique on the beating heart. Warfarin sodium was stopped three days prior to the operation while fondaparinux sodium was begun twice a day. The operation was successfully performed and no postoperative complications were observed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22821651      PMCID: PMC3445393          DOI: 10.1093/icvts/ivs329

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

1.  Strategies in heparin-induced thrombocytopenia.

Authors:  Alexander Wahba
Journal:  Multimed Man Cardiothorac Surg       Date:  2011-01-01

2.  Heparin-induced thrombocytopenia: real-world issues.

Authors:  Lori-Ann Linkins; Theodore E Warkentin
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

3.  Comparison of inflow occlusion on the beating heart with cardiopulmonary bypass in the extraction of a mass lesion or a foreign body from the right heart.

Authors:  Orhan Gokalp; Ismail Yurekli; Levent Yilik; Serdar Bayrak; Tayfun Goktogan; Erdinc Arikan; Ufuk Yetkin; Ali Gurbuz
Journal:  Eur J Cardiothorac Surg       Date:  2010-10-08       Impact factor: 4.191

Review 4.  Heparin-induced thrombocytopenia and cardiac surgery.

Authors:  Theodore E Warkentin; Andreas Greinacher
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

5.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

  5 in total
  1 in total

Review 1.  Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.

Authors:  Gowthami M Arepally; Thomas L Ortel
Journal:  Blood       Date:  2021-06-01       Impact factor: 25.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.